URS
MIRM icon

Utah Retirement Systems’s Mirum Pharmaceuticals MIRM Stock Holding History

Utah Retirement Systems’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,577
Closed -$492K – 988
2024
Q1 		$492K Hold
19,577
– – 0.01% 785
2023
Q4 		$578K Buy
+19,577
New +$592K 0.01% 786
2023
Q3 		– Sell
-17,909
Closed -$463K – 990
2023
Q2 		$463K Buy
+17,909
New +$476K 0.01% 827

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Utah Retirement Systems's MIRM Position: Q2 2024 in Review

Utah Retirement Systems sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 19,577 shares — an estimated $492K sold.

Utah Retirement Systems first reported a position in MIRM in Q2 2023 and held it in 3 quarters. The position peaked at $578K in Q4 2023. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • Utah Retirement Systems reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Utah Retirement Systems sold 19,577 Mirum Pharmaceuticals shares in Q2 2024, an estimated $492K.
  • Utah Retirement Systems first reported a position in Mirum Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Utah Retirement Systems's Mirum Pharmaceuticals position peaked at $578K in Q4 2023.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Utah Retirement Systems's 13F filing for Q2 2024, filed 14 Aug 2024.